Members Trust’s Eli Lilly LLY Stock Holding History

Members Trust’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$623K	Sell	677 -5	-0.7%	-$5.07K	0.02%	81
2025 Q4	$733K	Buy	682 +32	+5%	+$30.6K	0.02%	67
2025 Q3	$496K	Sell	650 -32	-5%	-$23.8K	0.02%	89
2025 Q2	$532K	Buy	682 +72	+12%	+$55.9K	0.02%	76
2025 Q1	$504K	Buy	610 +183	+43%	+$152K	0.02%	75
2024 Q4	$330K	Buy	427 +17	+4%	+$14.1K	0.01%	90
2024 Q3	$363K	Buy	410 +92	+29%	+$82.7K	0.01%	86
2024 Q2	$288K	Sell	318 -5	-2%	-$4K	0.01%	99
2024 Q1	$251K	Buy	+323	New	+$230K	0.01%	101
2022 Q1	–	Sell	-1,202	Closed	-$332K	–	122
2021 Q4	$332K	Buy	1,202 +6	+0.5%	+$1.52K	0.01%	92
2021 Q3	$276K	Buy	1,196 +38	+3%	+$9.38K	0.01%	100
2021 Q2	$266K	Sell	1,158 -284	-20%	-$57K	0.01%	106
2021 Q1	$269K	Buy	+1,442	New	+$282K	0.01%	91

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Members Trust's LLY Position: Q1 2026 in Review

Members Trust reduced its Eli Lilly (LLY) stake by 0.73% in Q1 2026, selling an estimated $5.07K and leaving 677 shares worth $623K. The position accounts for 0.02% of the portfolio, ranked #81.

Members Trust first reported a position in LLY in Q1 2021 and has held it in 13 quarters since. The position peaked at $733K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Members Trust held 677 shares of Eli Lilly worth $623K as of Q1 2026.
Members Trust sold 5 Eli Lilly shares in Q1 2026, an estimated $5.07K.
Eli Lilly made up 0.02% of Members Trust's portfolio in Q1 2026, its #81 holding.
Members Trust first reported a position in Eli Lilly in Q1 2021 and has held it in 13 quarters since.
Members Trust's Eli Lilly position peaked at $733K in Q4 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Members Trust's 13F filing for Q1 2026, filed 4 May 2026.